HBV-IN-52

CAT: 0804-HY-176059Size: 1 EachDry Ice: NoHazardous: No

1 / 1

CAT#:0804-HY-176059Size:1 Each

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

HBV-IN-52 is a selective HBV inhibitor. HBV-IN-52 is a Neplanocin A derivative that demonstrates significant activity against HBV replication with EC50 = 0.96 μM. HBV-IN-52 can inhibit HBsAg secretion (EC50 = 0.82 μM. HBV-IN-52 can be studied in research for chronic hepatitis B (CHB) infections[1].

UNSPSC

12352005

Target

HBV

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Smiles

OCC1=C[C@@H](N2N=C(I)C3=C2N=CN=C3C)[C@H](O)[C@@H]1O

Molecular Formula

C12H13IN4O3

Molecular Weight

388.16

References & Citations

[1]Kasula M, et al., Pyrazolo[3,4-d]pyrimidine-based neplanocin analogues identified as potential de novo pharmacophores for dual-target HBV inhibition. RSC Med Chem. 2025 Feb 20.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Related Products

Catalog	Name
HY-146395	HBV-IN-23
HY-149435	HBV-IN-36
HY-144047	HBV-IN-16
HY-149815	HBV-IN-33
HY-148780	HBV-IN-29
HY-146394	HBV-IN-22
HY-148781	HBV-IN-30
HY-145050	HBV-IN-7
HY-145049	HBV-IN-6
HY-162795	HBV-IN-47

Alternative Products

Catalog	Name
GTR19257783-01	HBV-IN-52
ant-150	HBV
P525235	HBV-C Protein (C-His, HBV)
LV1601	HBV(+) and HBV(-) noncancerous liver tissue array
BA1849-10	HBV-IN-37
601090020	Truenat™ HBV
FSD89784-01	HBV-IN-4
T209597-01	HBV-IN-45
T89131-01	HBV-IN-47
T63795-01	HBV-IN-6

HBV-IN-52

Related Products

Alternative Products

Popular Products